Boards & Committees - I2C2

International & Inter-Society Cordination Committee (I2C2)


Strategies for Engagement and Collaboration With Other Medical/Scientific Societies ("Rules of Engagement") (PDF)



PAST COMMITTEE MEETING REPORT:

2014 I2C2 Committee Report to the Board (PDF)



COMMITTEE COMPOSITION

  • The I2C2 shall consist of two Co-Chairs, one broadly responsible for international issues and one broadly responsible for inter-society issues, appointed by the Board of Directors and serving 4-year staggered terms.
  • The leader of each Scientific Council I2C2 Workforce shall serve on the Committee.
  • The Chairs of the Standards and Guidelines Committee, the Education Committee, the Finance Committee (or a Finance Committee representative), and the Registries and Databases Committee shall also serve on the Committee.
  • The Co-Chairs may appoint up to 4 additional ad hoc members as needed for renewable 2-year terms.
  • Ambassadors shall also be appointed to represent each interested country/geographic region. (see below)
COMMITTEE RESPONSIBILITIES

International
  • Identify opportunities to enhance clinical, regulatory  and scientific aspects of heart and lung transplantation, mechanical circulatory support and management of advanced heart and lung disease in nations and regions with limited experience in and infrastructure devoted to these diseases and issues.
  • Facilitate the provision of clinical and scientific expertise to governmental organizations (i.e., Ministries of Health, grant funding organizations) when requested by local medical/scientific organizations, academic institutions and/or hospitals; such assistance will be provided in the context of standards and guidelines that have been established and/or endorsed by the ISHLT.
  • Identify opportunities to foster exchanges of scientific information and collaboration, including in the development of translational and transnational research projects, the establishment of international registries or biobanks which extend discoveries at the bench to the clinical arena, and multicenter and multinational clinical trials.
  • Accomplish these aims while respecting the rules and political structures of local organizations with whom the ISHLT has engaged.
  • The I2C2 Workforce leader(s) from the relevant Scientific Council(s) will be responsible for working with their Scientific Council leadership to submit the resulting initiatives to the relevant Committee(s) who will review each submission and ultimately seek Board approval if warranted.
  • The implementation of the resulting initiatives will be through the relevant ISHLT Committees and Councils.
Inter-Society
  • Identify scientific/clinical areas and organizations where collaboration with those organizations with expertise in those areas would enhance the scientific, clinical, and educational missions of the ISHLT.
  • Facilitate the establishment of liaisons with such other organizations and facilitate communication and collaboration with these organizations.
  • Identify and facilitate opportunities for the development of joint sessions with other Societies at the ISHLT Annual Meeting.
  • Identify and facilitate opportunities for the development of joint sessions at the conferences of other medical/scientific societies.
  • Identify and facilitate opportunities for the development of joint standards and guidelines with other medical/scientific societies.
  • The I2C2 Workforce leader(s) from the relevant Scientific Council(s) will be responsible for working with their Scientific Council leadership to submit the resulting initiatives to the relevant Committee(s) who will review each submission and ultimately seek Board approval if warranted.
  • The relevant ISHLT Committees and Councils will be responsible for ultimate implementation of Board approved initiatives.
Ambassadors

Ambassadors are appointed after an individual contacts the Co-Chairs of I2C2 wishing to represent their country / geographic area.  Applicants will demonstrate a clear commitment to developing thoracic organ transplantation and end stage heart and lung failure therapies in their region.  Ambassadors will be appointed to serve a 3 year term which may be renewed by the I2C2 Committee Co-Chairs for an additional two years. Letters of interest are sought from all countries and geographic regions, especially those outside North America and Western Europe. Applicants must be members of ISHLT.

Ambassador Responsibilities
  • Formally represent their country and/or global region within the I2C2 committee.
  • Notify I2C2 of any issues of relevance to ISHLT arising within their global area.
  • Encourage their country/regionís governmental agency or institutions to submit data to the ISHLT Registries.
  • Liaise with national or regional Societies that share interests or members with ISHLT within their geographic zone to build partnerships and to facilitate educational and training opportunities.
  • Work with I2C2 on any geographic area-specific projects as needed.
  • Provide a brief annual report on regional transplant issues at the I2C2 Committee meeting each year.
COMMITTEE CO-CHAIRS:

INTERNATIONAL
Andreas Zuckermann, MD (2017)
University of Vienna
Vienna, AUSTRIA
43-1-40400-5643
andreas.zuckermann@meduniwien.ac.at

INTER-SOCIETAL
Howard J. Eisen, MD, FAHA, FACC, FACP (2019)
Drexel University College of Medicine and Hahnemann University Hospital
Philadelphia, PA, USA
215-762-5080
Howard.Eisen@DrexelMed.edu
Board of Directors Liaison
Hermann Reichenspurner, MD, PhD
University Heart Center Hamburg
Hamburg, GERMANY
49-40-74105-2440
hcr@uke.de
Standards and Guidelines Committee Chair
David O. Taylor, MD
Cleveland Clinic Foundation
Cleveland, OH, USA
216-444-2492
taylord2@ccf.org
Director of Educational Affairs
Christopher H. Wigfield, MD, FRCS(C/Th)
Loyola University Medical Center
Maywood, Illinois, USA
708-327-2488
cwigfield@lumc.edu
Finance Committee Chair
Stuart C. Sweet, MD, PhD
St. Louis Children's Hospital
St. Louis, Missouri, USA
314-454-2694
sweet@kids.wustl.edu
Thoracic Registry Medical Director
Josef Stehlik, MD, MPH
University of Utah
Salt Lake City, Utah, USA
801-585-2340
josef.stehlik@hsc.utah.edu
COUNCIL WORKFORCE LEADERS:

Heart Failure and Transplantation Council
Daniel H. Kim, MD (2018)
University of Alberta Medical School
Edmonton, AB, CANADA
780-407-7206
dk@ualberta.ca
Infectious Diseases Council
Martha L. Mooney, MD (2017)
Sentara Norfolk Transplant Center/EVMS
Norfolk, Virginia, USA
757-388-3803
mooneyml@evms.edu
Junior Faculty and Trainee Council
Reema Hasan, MD (2016)
University of Michigan Cardiovascular
Ann Arbor, Michigan, USA
734-232-6793
hasanr@med.umich.edu
Mechanical Circulatory Support Council
Sean P. Pinney, MD (2017)
Mount Sinai Medical Center
New York, New York, USA
212-241-9723
sean.pinney@mssm.edu
Nursing, Health Sciences and Allied Health Council
Pamela S Combs, PhD, RN
Seton Medical Center
Austin, TX, USA
502-592-9027
pscombs@seton.org
Pathology Council
Annalisa Angelini, MD (2018)
University of Padua
Padua, ITALY
annalisa.angelini@unipd.it
Pediatric Transplantation Council
James D. St. Louis , MD (2018)
University of Missouri
Kansas City, MO, USA
816-302-8026
sdstlouis@cmh.edu
Pharmacy and Pharmacology Council
Rochelle M Gellatly, PharmD (2016)
Senior Pharmacist -
Text SizeIncrease Font SizeDecrease Font Size